Neuralink is developing a fully integrated, implantable BCI to restore neurological function and, eventually, enhance human capability. Its system combines neural recording, robotic implantation, and real-time signal processing for applications in paralysis, with future extensions to vision and speech restoration. Founded in 2016 by Elon Musk, the company has begun human trials and raised $650 million in Series C funding to expand clinical testing and manufacturing.

Neuralink is developing a fully integrated, implantable BCI to restore neurological function and, eventually, enhance human capability. Its system combines neural recording, robotic implantation, and real-time signal processing for applications in paralysis, with future extensions to vision and speech restoration.

Neuralink

Full Memo

In-depth resources

See open roles

Similar Companies

Stay in touch